Published in Ann Intern Med on June 01, 1982
Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci U S A (1991) 5.46
Toxic shock syndrome. Arch Dis Child (1985) 1.58
Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus. J Clin Microbiol (1990) 1.54
Toxic shock syndrome. Clin Microbiol Rev (1988) 1.37
Toxic shock syndrome in the United States: surveillance update, 1979 1996. Emerg Infect Dis (2000) 1.35
Presence of toxic shock toxin in toxic shock and other clinical strains of Staphylococcus aureus. Infect Immun (1984) 1.17
Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits. Infect Immun (1986) 1.05
Production and characterization of monoclonal antibodies to toxic shock syndrome toxin 1 and use of a monoclonal antibody in a rapid, one-step enzyme-linked immunosorbent assay for detection of picogram quantities of toxic shock syndrome toxin 1. J Clin Microbiol (1987) 1.00
Prevalence of toxic shock syndrome toxin 1 (TSST-1)-producing strains of Staphylococcus aureus and antibody to TSST-1 among healthy Japanese women. J Clin Microbiol (2008) 0.97
Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndrome. J Clin Immunol (2007) 0.90
Determination by western blot (immunoblot) of seroconversions to toxic shock syndrome (TSS) toxin 1 and enterotoxin A, B, or C during infection with TSS- and non-TSS-associated Staphylococcus aureus. Infect Immun (1989) 0.90
Studies on staphylococci from toxic shock syndrome in France, 1981-1983. J Hyg (Lond) (1985) 0.85
Toxic shock syndrome due to occult postoperative wound infection. West J Med (1983) 0.84
Toxic shock syndrome in Utah--1976 to 1983. West J Med (1985) 0.82
Toxic shock syndrome presenting as cerebral infarct. J Neurol Neurosurg Psychiatry (1984) 0.81
Quantitative vaginal microflora in women convalescent from toxic shock syndrome and in healthy controls. Infect Immun (1984) 0.80
Toxic shock syndrome: chronology of state and federal epidemiologic studies and regulatory decision-making. Public Health Rep (1984) 0.76
Production of toxic-shock-associated protein(s) in Staphylococcus aureus strains isolated from 1956 through 1982. J Clin Microbiol (1984) 0.75
Maxillary sinusitis--the focus of toxic shock syndrome in a male patient. West J Med (1987) 0.75
Sequence of the toxic shock syndrome toxin gene (tstH) borne by strains of Staphylococcus aureus isolated from patients with Kawasaki syndrome. Infect Immun (1996) 0.75
A confirmed case of toxic shock syndrome associated with the use of a menstrual cup. Can J Infect Dis Med Microbiol (2015) 0.75
Cisplatin therapy-associated recurrent toxic shock syndrome. West J Med (1991) 0.75
Impact of Advertising on Tampon Wear-time Practices. Clin Med Insights Womens Health (2015) 0.75
Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med (1983) 25.72
The spirochetal etiology of Lyme disease. N Engl J Med (1983) 21.59
Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N Engl J Med (1985) 11.94
Epidemic listeriosis--evidence for transmission by food. N Engl J Med (1983) 11.72
The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable? Emerg Infect Dis (1997) 9.69
Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis (1981) 8.40
Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med (1980) 7.85
Listeriosis. JAMA (1989) 7.06
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med (2000) 6.58
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med (1997) 5.73
Epidemiology of human listeriosis. Clin Microbiol Rev (1991) 5.21
Public health policy for preventing violence. Health Aff (Millwood) (1993) 5.17
Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA (1993) 4.63
The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis (1999) 4.37
The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis (1998) 4.33
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis (1999) 3.92
Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease. J Infect Dis (1984) 3.91
Legionella pneumonia in the United States: the distribution of serogroups and species causing human illness. J Infect Dis (1984) 3.81
Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA (1993) 3.31
Predicting Mycobacterium avium complex bacteremia in patients infected with human immunodeficiency virus: a prospectively validated model. Clin Infect Dis (1994) 3.30
Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10. J Infect Dis (1985) 3.16
Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med (1982) 3.12
An outbreak of type 4b Listeria monocytogenes infection involving patients from eight Boston hospitals. Arch Intern Med (1986) 3.12
Toxic-shock syndrome not associated with menstruation. A review of 54 cases. Lancet (1982) 3.10
Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA (1991) 3.09
Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet (1989) 3.09
The carrier state: Neisseria meningitidis. J Antimicrob Chemother (1986) 3.00
Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Appl Environ Microbiol (1990) 2.90
Isolation of Legionella pneumophila from hospital shower heads. Ann Intern Med (1981) 2.89
Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA (1985) 2.87
Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med (2000) 2.85
Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med (1980) 2.85
Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria Study Group. JAMA (1992) 2.82
Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis (1990) 2.80
Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA (1990) 2.79
Risk factors for group B streptococcal disease in adults. Ann Intern Med (1995) 2.78
DNA characterization of the spirochete that causes Lyme disease. J Clin Microbiol (1984) 2.71
Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Lancet (2000) 2.67
Campylobacter hyointestinalis associated with human gastrointestinal disease in the United States. J Clin Microbiol (1987) 2.59
Validation of Legionella pneumophila indirect immunofluorescence assay with epidemic sera. J Clin Microbiol (1981) 2.56
Comparison of sputum induction with fiberoptic bronchoscopy in the diagnosis of tuberculosis: experience at an acquired immune deficiency syndrome reference center in Rio de Janeiro, Brazil. Am J Respir Crit Care Med (2000) 2.51
Investigation of an outbreak of listeriosis: new hypotheses for the etiology of epidemic Listeria monocytogenes infections. J Infect Dis (1989) 2.42
Association of sporadic listeriosis with consumption of uncooked hot dogs and undercooked chicken. Lancet (1988) 2.42
Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis (1985) 2.39
Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet (1985) 2.39
A new Legionella species, Legionella feeleii species nova, causes Pontiac fever in an automobile plant. Ann Intern Med (1984) 2.35
The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA. Lancet (1996) 2.35
Reactivity of serum from patients with suspected legionellosis against 29 antigens of legionellaceae and Legionella-like organisms by indirect immunofluorescence assay. J Infect Dis (1983) 2.28
Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med (1986) 2.26
Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins. JAMA (1985) 2.16
Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group. JAMA (1992) 2.15
Bacillary angiomatosis and bacillary splenitis in immunocompetent adults. Ann Intern Med (1993) 2.14
Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J Infect Dis (1998) 2.11
Global epidemiology of meningococcal disease. Clin Microbiol Rev (1989) 2.11
Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group. J Clin Microbiol (1996) 2.08
Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet (1988) 2.06
Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA (1988) 2.06
Epidemiologic aspects of legionellosis. Epidemiol Rev (1979) 2.03
The global distribution of Lyme disease. Rev Infect Dis (1985) 1.99
Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med (1984) 1.96
Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med (1998) 1.96
Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA (1985) 1.91
Infection caused by Francisella philomiragia (formerly Yersinia philomiragia). A newly recognized human pathogen. Ann Intern Med (1989) 1.89
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis (1997) 1.86
The epidemiology of listeriosis in the United States--1986. Listeriosis Study Group. Am J Epidemiol (1991) 1.84
Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis (1990) 1.77
Risk factors for primary invasive Haemophilus influenzae disease: increased risk from day care attendance and school-aged household members. J Pediatr (1985) 1.76
Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex. Ann Intern Med (1983) 1.75
Nosocomial Legionnaires' disease. Epidemiologic demonstration of cooling towers as a source. JAMA (1985) 1.74
Lyme disease: a selective medium for isolation of the suspected etiological agent, a spirochete. J Clin Microbiol (1984) 1.72
Effect of pregnancy on the risk of developing active tuberculosis. J Infect Dis (1996) 1.71
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States: 1992 to 1994 and 1996 to 1998. Antimicrob Agents Chemother (2001) 1.70
Trans-isolate medium: a new medium for primary culturing and transport of Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. J Clin Microbiol (1984) 1.70
Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers. Appl Environ Microbiol (1988) 1.67
Mycobacterium avium complex in water, food, and soil samples collected from the environment of HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.66
The use of serologic tests for Lyme disease in a prepaid health plan in California. JAMA (1994) 1.65
Rapid diagnosis of Legionnaires' disease by direct immunofluorescent staining. Ann Intern Med (1979) 1.65
Outbreak of neonatal listeriosis associated with mineral oil. Pediatr Infect Dis J (1991) 1.64
Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis. JAMA (1993) 1.63